Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Life sciences
Insights from FDA complete response letters: Preventing costly drug approval delays
FDA’s complete response letters reveal the importance of addressing issues early for biopharma companies. … READ MORE >
5 things to know in life sciences: Week of Aug. 24, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Aug. 17, 2026
New regulatory framework explored for generative AI medical devices. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Aug. 10, 2026
UK becomes first European country to approve oral GLP-1 medicine. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Aug. 3, 2026
Biotech IPO resurgence continues. This and more in this week’s life sciences industry update. … READ MORE >
5 things to know in life sciences: Week of July 27, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of July 20, 2026
New clues for borderline personality disorder. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of July 13, 2026
Biotech IPO activity remains strong in 2026. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of July 6, 2026
Biosimilar adoption in the U.S. is increasing as more biologic drugs face patent expirations. This and more in this week’s life sciences update. … READ MORE >